Aurinia Pharmaceuticals Inc. (AUPH) at a glance

Aurinia Pharmaceuticals Inc. (AUPH) is a mid-cap Healthcare company. It trades at $16.27, with a P/E of 7.3, a 100% profit margin and revenue growth of 24.4%. It does not pay a dividend. Vestovix scores it 64/100 overall. Its strongest dimension is Value (99/100) and its weakest is Safety (24/100). It carries above-market volatility, so expect larger swings.

Price

$16.28

Market cap

$2.03B

P/E ratio

7.3

Dividend yield

None

Beta

1.43

52-week range

$10.34 to $19.25